|
|
Sabine Cepok, Dun Zhou, Rajneesh Srivastava, Stefan Nessler, Susanne Stei, Konrad Büssow, Norbert Sommer, Bernhard Hemmer
J Clin Invest. 2005;
115(5):1352
doi:10.1172/JCI23661
Abstract |
Full text
| PDF

M
S is a chronic inflammatory and demyelinating disease of the CNS with as yet unknown etiology. A hallmark of this disease is the occurrence of oligoclonal IgG antibodies in the cerebrospinal fluid (CSF). To assess the specificity of these antibodies, we screened protein expression arrays containing 37,000 tagged proteins. The 2 most frequent MS-specific reactivities were further mapped to identify the underlying high-affinity epitopes. In both cases, we identified peptide sequences derived from EBV proteins expressed in latently infected cells. Immunoreactivities to these EBV proteins, BRRF2 and EBNA-1, were significantly higher in the serum and CSF of MS patients than in those of control donors. Oligoclonal CSF IgG from MS patients specifically bound both EBV proteins. Also, CD8+ T cell responses to latent EBV proteins were higher in MS patients than in controls. In summary, these findings demonstrate an increased immune response to EBV in MS patients, which suggests that the virus plays an important role in the pathogenesis of disease.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(29)
| Title and authors |
Publication |
Year |
Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis
Bharath Wootla, Aleksandar Denic, B. Mark Keegan, Jeffrey L. Winters, David Astapenko, Arthur E. Warrington, Allan J. Bieber, Moses Rodriguez
|
Neurology Research International
|
2011 |
Environmental risk factors in multiple sclerosis
Klaus Lauer
|
Expert Rev Neurotherapeutics
|
2010 |
Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?
Bernd Krone, John M Grange
|
Autoimmune Diseases
|
2010 |
Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.
Carlo Contini, Silva Seraceni, Rosario Cultrera, Massimiliano Castellazzi, Enrico Granieri, Enrico Fainardi
|
Interdisciplinary Perspectives on Infectious Diseases
|
2010 |
Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
M. P. Pender
|
Brain
|
2009 |
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Simon N Willis, Christine Stadelmann, Scott J Rodig, Tyler Caron, Stefan Gattenloehner, Scott S Mallozzi, Jill E Roughan, Stefany E Almendinger, Megan M Blewett, Wolfgang Brück, David A Hafler, Kevin C O'Connor
|
Brain
|
2009 |
Environmental risk factors in multiple sclerosis
M. Pugliatti, H. F. Harbo, T. Holmøy, M. T. Kampman, K.-M. Myhr, T. Riise, C. Wolfson
|
Acta Neurologica Scandinavica
|
2008 |
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
S. Jilek, M. Schluep, P. Meylan, F. Vingerhoets, L. Guignard, A. Monney, J. Kleeberg, G. Le Goff, G. Pantaleo, R. A. Du Pasquier
|
Brain
|
2008 |
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Jan D Lünemann, Ilijas Jelcić, Susanne Roberts, Andreas Lutterotti, Björn Tackenberg, Roland Martin, Christian Münz
|
J. Exp. Med.
|
2008 |
Multiple-Sklerose-Update zur Pathophysiologie und neuen immuntherapeutischen Ansätzen
C. Kleinschnitz, S.G. Meuth, B.C. Kieseier, H. Wiendl
|
Nervenarzt
|
2007 |
|